Single serine on TSC2 exerts biased control over mTORC1 activation mediated by ERK1/2 but not Akt

Brittany L Dunkerly-Eyring1,2, Shi Pan1, Miguel Pinilla-Vera1

  • 1Division of Cardiology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Life Science Alliance
|March 15, 2022
PubMed

Insights

Tuberous sclerosis complex-2 (TSC2) phosphorylation at Serine 1364 specifically controls extracellular signal-regulated kinase (ERK1/2)-mediated mammalian target of rapamycin complex 1 (mTORC1) activation, not Akt-dependent pathways. This finding offers a targeted approach to modulate mTORC1 signaling.

Area of Science:

  • Cellular signaling pathways
  • Molecular biology
  • Biochemistry

Background:

  • Tuberous sclerosis complex-2 (TSC2) is a key negative regulator of mTORC1 signaling.
  • Phosphorylation of TSC2 by Akt and ERK1/2 kinases activates mTORC1.
  • Serine 1364 (S1364) on TSC2 is a critical modification site influencing mTORC1 activity.

Purpose of the Study:

  • To investigate the specific role of TSC2 S1364 phosphorylation in modulating mTORC1 activation by different signaling pathways.
  • To differentiate between ERK1/2-dependent and Akt-dependent TSC2-mTORC1 activation.
  • To determine the in vivo relevance of S1364 modifications in metabolic conditions.

Main Methods:

  • Utilized phospho-mimetic (S1364E) and phospho-silenced (S1364A) TSC2 mutations in cellular models.
  • Stimulated mTORC1 signaling with various agonists including Endothelin-1, insulin, PDGF, and thrombin.
  • Assessed mTORC1 activation in response to S1364 modifications under basal and stimulated conditions, including in vivo models of diet-induced obesity.

Main Results:

  • TSC2 S1364 modification specifically impacts ERK1/2-dependent mTORC1 activation, not Akt-dependent pathways.
  • Endothelin-1 and thrombin-induced mTORC1 activation were modulated by S1364 mutations, while insulin and PDGF effects were unaltered.
  • S1364 modifications showed negligible effects on mTORC1 regulation by energy status and were unaltered in diet-induced obesity and diabetes models in vivo.

Conclusions:

  • TSC2 S1364 phosphorylation provides a selective mechanism for controlling ERK1/2-mediated mTORC1 activation.
  • This site offers a means to genetically distinguish pathological mTORC1 stimuli from physiological ones.
  • The findings highlight the pathway-specific role of TSC2 S1364 in mTORC1 regulation.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.3K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.5K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K